Literature DB >> 8922736

The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit.

V Pichette1, D Geadah, P du Souich.   

Abstract

1. The present study aimed to investigate the influence of hypoalbuminaemia on the pharmacokinetics and pharmacodynamics of furosemide. Hypoalbuminaemia was produced by repeated plasmapheresis, to attain plasma albumin concentrations of 21.6 +/- 0.9 g l-1, compared with 33.0 +/- 0.6 g l-1 in controls (P < 0.001). The per cent of bound furosemide in hypoalbuminaemic rabbits (90.8 +/- 0.7%) was lower than that in control rabbits (97.4 +/- 0.5%, P < 0.001). The kinetics of intravenous furosemide (2.5 mg kg-1) were studied in control (n = 6) and hypoalbuminaemic rabbits (n = 6). 2. To assess the effect of hypoalbuminaemia on extrarenal clearance of furosemide, functional anephria was induced by ligating the renal pedicles of 12 rabbits, which were segregated in two groups, with and without hypoalbuminaemia. 3. In the control group, total, urinary and metabolic clearances of furosemide were 11.8 +/- 1.0, 5.0 +/- 0.4 and 6.8 +/- 0.6 ml min-1 kg-1, respectively. Compared with control rabbits, in hypoalbuminaemic rabbits, total clearance of furosemide increased by 40% (P < 0.001), result of the enhancement of furosemide metabolic clearance (C1m) from 5 to 10 ml min-1 kg-1 (P < 0.01). In hypoalbuminaemic rabbits, urinary excretion of furosemide was reduced by 26% (2451 +/- 115 vs 1818 +/- 134 micrograms h-1, P < 0.01). In anephric rabbits, furosemide total clearance was 1.77 +/- 0.12 ml min-1 kg-1, value not affected by hypoalbuminaemia, confirming that the increase in C1m induced by hypoalbuminaemia occurs in the kidneys. 4. Compared with controls, in hypoalbuminaemic rabbits, the rate of urinary excretion (142 +/- 9 vs 74 +/- 8 ml h-1, P < 0.001) and the rate of excretion of sodium (18.6 +/- 0.9 vs 9.9 +/- 0.9 mmol h-1, P < 0.001) were very much reduced. However, the dose-response curves were not different. 5. In conclusion, hypoalbuminaemia is associated with an increase in renal metabolic clearance of furosemide, possibly because of the increase in furosemide unbound concentration, and a decrease in the diuretic/natriuretic effect of furosemide, secondary to a reduction in furosemide tubular secretion. Thus, albumin facilitates the renal secretion of organic anions but not their metabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922736      PMCID: PMC1915948          DOI: 10.1111/j.1476-5381.1996.tb15755.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Determination of inulin by means of resorcinol.

Authors:  G E SCHREINER
Journal:  Proc Soc Exp Biol Med       Date:  1950-05

2.  Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.

Authors:  M Homeida; C Roberts; R A Branch
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

3.  Relationship between tubular secretion of furosemide and its saluretic effect.

Authors:  B Odlind
Journal:  J Pharmacol Exp Ther       Date:  1979-03       Impact factor: 4.030

Review 4.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

5.  Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion.

Authors:  T P Green; B L Mirkin
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

6.  Disposition and diuretic effect of furosemide in the nephrotic syndrome.

Authors:  E Keller; G Hoppe-Seyler; P Schollmeyer
Journal:  Clin Pharmacol Ther       Date:  1982-10       Impact factor: 6.875

7.  Nonrenal clearance of furosemide as a cause of diuretic response variability in the rat.

Authors:  C Lambert; G Caillé; P du Souich
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

8.  Suppression of para-aminohippurate transport in the isolated perfused kidney by an inhibitor of protein binding in uremia.

Authors:  T A Depner; T Sanaka; L A Stanfel
Journal:  Am J Kidney Dis       Date:  1984-01       Impact factor: 8.860

9.  Plasma clearance of sulfobromophthalein and its interaction with hepatic binding proteins in normal and analbuminemic rats: is plasma albumin essential for vectorial transport of organic anions in the liver?

Authors:  M Inoue; K Okajima; S Nagase; Y Morino
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

10.  Transport and metabolism of [3H]morphine in isolated, nonperfused proximal tubular segments of the rabbit kidney.

Authors:  C Schäli; F Roch-Ramel
Journal:  J Pharmacol Exp Ther       Date:  1982-12       Impact factor: 4.030

View more
  10 in total

Review 1.  Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.

Authors:  Jozine M ter Maaten; Mattia A E Valente; Kevin Damman; Hans L Hillege; Gerjan Navis; Adriaan A Voors
Journal:  Nat Rev Cardiol       Date:  2015-01-06       Impact factor: 32.419

Review 2.  Treatment of Disorders of Sodium Balance in Chronic Kidney Disease.

Authors:  David H Ellison
Journal:  Adv Chronic Kidney Dis       Date:  2017-09       Impact factor: 3.620

Review 3.  Diuretic use in renal disease.

Authors:  Domenic A Sica
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

Review 4.  Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug.

Authors:  Filippo Mariano; Alberto Mella; Marco Vincenti; Luigi Biancone
Journal:  J Nephrol       Date:  2019-05-14       Impact factor: 3.902

5.  Serum and Urine Albumin and Response to Loop Diuretics in Heart Failure.

Authors:  Antonios Charokopos; Matthew Griffin; Veena S Rao; Lesley Inker; Krishna Sury; Jennifer Asher; Jeffrey Turner; Devin Mahoney; Zachary L Cox; F Perry Wilson; Jeffrey M Testani
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-22       Impact factor: 8.237

6.  Efficacy of furosemide-albumin compared with furosemide in critically ill hypoalbuminemia patients admitted to intensive care unit: a prospective randomized clinical trial.

Authors:  Ata Mahmoodpoor; Sahra Zahedi; Arezou Pourakbar; Hamed Hamishehkar; Kamran Shadvar; Parina Asgharian; Farnaz Shahabi; Hadi Hamishehkar
Journal:  Daru       Date:  2020-04-14       Impact factor: 3.117

7.  The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study.

Authors:  Bunyong Phakdeekitcharoen; Kochawan Boonyawat
Journal:  BMC Nephrol       Date:  2012-08-29       Impact factor: 2.388

8.  Bioengineered kidney tubules efficiently excrete uremic toxins.

Authors:  J Jansen; M Fedecostante; M J Wilmer; J G Peters; U M Kreuser; P H van den Broek; R A Mensink; T J Boltje; D Stamatialis; J F Wetzels; L P van den Heuvel; J G Hoenderop; R Masereeuw
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

9.  Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction.

Authors:  Yuya Matsue; Jozine M Ter Maaten; Makoto Suzuki; Sho Torii; Satoshi Yamaguchi; Seiji Fukamizu; Yuichi Ono; Hiroyuki Fujii; Takeshi Kitai; Toshihiko Nishioka; Kaoru Sugi; Yuko Onishi; Makoto Noda; Nobuyuki Kagiyama; Yasuhiro Satoh; Kazuki Yoshida; Peter van der Meer; Kevin Damman; Adriaan A Voors; Steven R Goldsmith
Journal:  Clin Res Cardiol       Date:  2017-05-24       Impact factor: 5.460

10.  Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis.

Authors:  Tao Han Lee; George Kuo; Chih-Hsiang Chang; Yen Ta Huang; Chieh Li Yen; Cheng-Chia Lee; Pei Chun Fan; Jia-Jin Chen
Journal:  PLoS One       Date:  2021-12-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.